These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 37372545)
1. Advances in the Metabolic Mechanism and Functional Characteristics of Equol. Gong Y; Lv J; Pang X; Zhang S; Zhang G; Liu L; Wang Y; Li C Foods; 2023 Jun; 12(12):. PubMed ID: 37372545 [TBL] [Abstract][Full Text] [Related]
2. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy. Virk-Baker MK; Barnes S; Krontiras H; Nagy TR Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312 [TBL] [Abstract][Full Text] [Related]
3. Bacterial communities and metabolic activity of faecal cultures from equol producer and non-producer menopausal women under treatment with soy isoflavones. Guadamuro L; Dohrmann AB; Tebbe CC; Mayo B; Delgado S BMC Microbiol; 2017 Apr; 17(1):93. PubMed ID: 28415978 [TBL] [Abstract][Full Text] [Related]
4. The role of colonic bacteria in the metabolism of the natural isoflavone daidzin to equol. Rafii F Metabolites; 2015 Jan; 5(1):56-73. PubMed ID: 25594250 [TBL] [Abstract][Full Text] [Related]
5. Equol: a metabolite of gut microbiota with potential antitumor effects. Lv J; Jin S; Zhang Y; Zhou Y; Li M; Feng N Gut Pathog; 2024 Jul; 16(1):35. PubMed ID: 38972976 [TBL] [Abstract][Full Text] [Related]
6. Is equol the key to the efficacy of soy foods? Lampe JW Am J Clin Nutr; 2009 May; 89(5):1664S-1667S. PubMed ID: 19357217 [TBL] [Abstract][Full Text] [Related]
7. Maximizing the Estrogenic Potential of Soy Isoflavones through the Gut Microbiome: Implication for Cardiometabolic Health in Postmenopausal Women. Leonard LM; Choi MS; Cross TL Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276910 [TBL] [Abstract][Full Text] [Related]
8. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010). North American Menopause Society Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820 [TBL] [Abstract][Full Text] [Related]
9. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Setchell KD; Clerici C; Lephart ED; Cole SJ; Heenan C; Castellani D; Wolfe BE; Nechemias-Zimmer L; Brown NM; Lund TD; Handa RJ; Heubi JE Am J Clin Nutr; 2005 May; 81(5):1072-9. PubMed ID: 15883431 [TBL] [Abstract][Full Text] [Related]
10. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. Setchell KD; Brown NM; Lydeking-Olsen E J Nutr; 2002 Dec; 132(12):3577-84. PubMed ID: 12468591 [TBL] [Abstract][Full Text] [Related]
11. Long-term dietary habits affect soy isoflavone metabolism and accumulation in prostatic fluid in caucasian men. Hedlund TE; Maroni PD; Ferucci PG; Dayton R; Barnes S; Jones K; Moore R; Ogden LG; Wähälä K; Sackett HM; Gray KJ J Nutr; 2005 Jun; 135(6):1400-6. PubMed ID: 15930444 [TBL] [Abstract][Full Text] [Related]
12. Acute benefits of the microbial-derived isoflavone metabolite equol on arterial stiffness in men prospectively recruited according to equol producer phenotype: a double-blind randomized controlled trial. Hazim S; Curtis PJ; Schär MY; Ostertag LM; Kay CD; Minihane AM; Cassidy A Am J Clin Nutr; 2016 Mar; 103(3):694-702. PubMed ID: 26843154 [TBL] [Abstract][Full Text] [Related]
14. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health. Yuan JP; Wang JH; Liu X Mol Nutr Food Res; 2007 Jul; 51(7):765-81. PubMed ID: 17579894 [TBL] [Abstract][Full Text] [Related]
15. Soy isoflavone metabolite equol inhibits cancer cell proliferation in a PAP associated domain containing 5-dependent and an estrogen receptor-independent manner. Yamashita S; Lin I; Oka C; Kumazoe M; Komatsu S; Murata M; Kamachi S; Tachibana H J Nutr Biochem; 2022 Feb; 100():108910. PubMed ID: 34801689 [TBL] [Abstract][Full Text] [Related]
16. Influence of isoflavone intake and equol-producing intestinal flora on prostate cancer risk. Sugiyama Y; Masumori N; Fukuta F; Yoneta A; Hida T; Yamashita T; Minatoya M; Nagata Y; Mori M; Tsuji H; Akaza H; Tsukamoto T Asian Pac J Cancer Prev; 2013; 14(1):1-4. PubMed ID: 23534704 [TBL] [Abstract][Full Text] [Related]
17. Optimal cut-off value for equol-producing status in women: The Japan Nurses' Health Study urinary isoflavone concentration survey. Ideno Y; Hayashi K; Nakajima-Shimada J; Onizuka Y; Kishi M; Ueno T; Uchiyama S PLoS One; 2018; 13(7):e0201318. PubMed ID: 30048499 [TBL] [Abstract][Full Text] [Related]
18. Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, double-blind, and placebo-controlled trial in equol-producing postmenopausal women. Liu ZM; Ho SC; Chen YM; Ho S; To K; Tomlinson B; Woo J Mol Nutr Food Res; 2014 Apr; 58(4):709-17. PubMed ID: 24273218 [TBL] [Abstract][Full Text] [Related]
19. Potential Protective Effects of Equol (Soy Isoflavone Metabolite) on Coronary Heart Diseases-From Molecular Mechanisms to Studies in Humans. Zhang X; Veliky CV; Birru RL; Barinas-Mitchell E; Magnani JW; Sekikawa A Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835997 [TBL] [Abstract][Full Text] [Related]
20. [Research development on relation between equol and soy foods health effect]. Liu B; Qin L; Wang P Wei Sheng Yan Jiu; 2010 Nov; 39(6):784-6. PubMed ID: 21351654 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]